Furthermore, tumor-infiltrating CD8+ T cells in human breast cancer exhibit increased programmed death-ligand 1 (PD-L1) expression (Figure 1C), correlating with compromised immune functionality and subsequent T cell suppression (96). This evidence concerns the gene CD8A and neoplasm.